Inspire Medical Systems (INSP) Price to Sales (2018 - 2026)

Inspire Medical Systems has disclosed Price to Sales across 9 years of filings, most recently posting 6.43 for Q2 2026.

• In Q2 2026, Price to Sales fell 63.63% year-over-year to 6.43; the TTM figure through Jun 2026 stood at 1.43 (down 67.79% YoY), while the FY2025 annual figure was 2.89, down 57.91% from the prior year.
• Price to Sales came in at 6.43 for Q2 2026 at Inspire Medical Systems, down from 7.26 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 101.99 in Q1 2022 to a low of 6.43 in Q2 2026.
• Average Price to Sales over 5 years is 35.01, with a median of 31.18 recorded in 2024.
• Year-over-year, Price to Sales grew 14.07% in 2023 and tumbled 69.15% in 2025.
• Over 5 years, Price to Sales stood at 52.98 in 2022, then plunged by 41.04% to 31.24 in 2023, then declined by 26.37% to 23.0 in 2024, then slumped by 57.41% to 9.8 in 2025, then plunged by 34.37% to 6.43 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 6.43 in Q2 2026, 7.26 in Q1 2026, and 9.8 in Q4 2025.